Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH, Klinkenbijl JH, Orzalesi L, Bouma WH, van der Mijle HC, Nieuwenhuijzen GA, Veltkamp SC, Slaets L, Duez NJ, de Graaf PW, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JW, Belkacemi Y, Petignat P, Schinagl DA, Coens C, Messina CG, Bogaerts J, Rutgers EJ.
Lancet Oncol. 2014 Nov;15(12):1303-10. doi: 10.1016/S1470-2045(14)70460-7. Epub 2014 Oct 15.
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial.
Tinterri C, Gentile D, Gatzemeier W, Sagona A, Barbieri E, Testori A, Errico V, Bottini A, Marrazzo E, Dani C, Dozin B, Boni L, Bruzzi P, Fernandes B, Franceschini D, Spoto R, Torrisi R, Scorsetti M, Santoro A, Canavese G; SINODAR-ONE Collaborative Group.
Ann Surg Oncol. 2022 Sep;29(9):5732-5744. doi: 10.1245/s10434-022-11866-w. Epub 2022 May 12.
Lymph Node Imaging in Patients with Primary Breast Cancer: Concurrent Diagnostic Tools.
Marino MA, Avendano D, Zapata P, Riedl CC, Pinker K.
Oncologist. 2020 Feb;25(2):e231-e242. doi: 10.1634/theoncologist.2019-0427. Epub 2019 Oct 14.
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.
Tinterri C, Canavese G, Gatzemeier W, Barbieri E, Bottini A, Sagona A, Caraceni G, Testori A, Di Maria Grimaldi S, Dani C, Boni L, Bruzzi P, Fernandes B, Scorsetti M, Zambelli A, Gentile D; SINODAR-ONE Collaborative Group.
Br J Surg. 2023 Aug 11;110(9):1143-1152. doi: 10.1093/bjs/znad215.
Axillary Nodal Evaluation in Breast Cancer: State of the Art.
Chang JM, Leung JWT, Moy L, Ha SM, Moon WK.
Radiology. 2020 Jun;295(3):500-515. doi: 10.1148/radiol.2020192534. Epub 2020 Apr 21.
Axillary Lymph Node Inclusions.
Cimino-Mathews A.
Surg Pathol Clin. 2018 Mar;11(1):43-59. doi: 10.1016/j.path.2017.09.004. Epub 2017 Nov 29.
Non-invasive predictors of axillary lymph node burden in breast cancer: a single-institution retrospective analysis.
Ngai V, Tai JCJ, Taj S, Khanfar H, Sfakianakis E, Bakalis A, Baker R, Ahmed M.
Breast Cancer Res Treat. 2022 Sep;195(2):161-169. doi: 10.1007/s10549-022-06672-7. Epub 2022 Jul 21.
The effect of the tumor-to-skin distance on axillary lymph node metastasis in breast cancer.
Yur M, Aygen E, İlhan YS, Lale A, Ebiloğlu MF.
Rev Assoc Med Bras (1992). 2023 Apr 21;69(4):e20221277. doi: 10.1590/1806-9282.20221277. eCollection 2023.
Surgical treatment of breast cancer.
Tvedskov TF, Lautrup MD, Kroman NT, Christiansen PM.
Ugeskr Laeger. 2024 Mar 18;186(12):V01230033. doi: 10.61409/V01230033.
Prognostic value of extranodal extension in axillary lymph node-positive breast cancer.
Ma X, Yang X, Yang W, Shui R.
Sci Rep. 2021 May 5;11(1):9534. doi: 10.1038/s41598-021-88716-4.
